東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Novel synthetic drugs in migraine

Martelletti, Paolo.

FindBook

Google Book

Amazon

博客來

Novel synthetic drugs in migraine

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Novel synthetic drugs in migraine/ edited by Paolo Martelletti, Lars Edvinsson.
其他作者:	Martelletti, Paolo.
出版者:	Cham :Springer International Publishing : : 2022.,
面頁冊數:	ix, 109 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	Migraine - Treatment. -
電子資源:	https://doi.org/10.1007/978-3-030-95334-8
ISBN:	9783030953348

Novel synthetic drugs in migraine
Novel synthetic drugs in migraine[electronic resource] /edited by Paolo Martelletti, Lars Edvinsson. - Cham :Springer International Publishing :2022. - ix, 109 p. :ill., digital ;24 cm. - Headache,2197-6538. - Headache..

Published in the series Headache, endorsed by the European Headache Federation, this is the first book on the novel synthetic treatment of migraine with ditans (lasmiditan) and gepants (atogepant, ubrogepant, rimegepant, vazegepant) These drugs will provide additional options for people with migraine put at risk of side effects by other medications or with unsatisfactory response to previous drugs. There is now a sufficient amount of literature published to interest a wide multidisciplinary readership (general physicians, general neurologists, clinical psychologists, neurologists in training, and medical students) facing every day this burdensome disorder in their clinical practice. The book aims therefore at offering an overview of these new drugs for both acute and prophylactic treatments of migraine, covering studies on clinical evidence, tolerability, and the different stages of clinical development.

ISBN: 9783030953348

Standard No.: 10.1007/978-3-030-95334-8doiSubjects--Topical Terms:

1005999
Migraine
--Treatment.

LC Class. No.: RC392 / .N68 2022

Dewey Class. No.: 616.84912061

Novel synthetic drugs in migraine
LDR:01906nmm a2200325 a 4500 001 2300762
003 DE-He213
005 20220426215432.0
006 m d
007 cr nn 008maaau
008 230324s2022 sz s 0 eng d
020 $a 9783030953348 $q (electronic bk.)
020 $a 9783030953331 $q (paper)
024 7 $a 10.1007/978-3-030-95334-8 $2 doi
035 $a 978-3-030-95334-8
040 $a GP $c GP
041 0 $a eng
050 4 $a RC392 $b .N68 2022
072 7 $a MJ $2 bicssc
072 7 $a MED045000 $2 bisacsh
072 7 $a MJ $2 thema
082 0 4 $a 616.84912061 $2 23
090 $a RC392 $b .N937 2022
245 0 0 $a Novel synthetic drugs in migraine $h [electronic resource] / $c edited by Paolo Martelletti, Lars Edvinsson.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a ix, 109 p. : $b ill., digital ; $c 24 cm.
490 1 $a Headache, $x 2197-6538
520 $a Published in the series Headache, endorsed by the European Headache Federation, this is the first book on the novel synthetic treatment of migraine with ditans (lasmiditan) and gepants (atogepant, ubrogepant, rimegepant, vazegepant) These drugs will provide additional options for people with migraine put at risk of side effects by other medications or with unsatisfactory response to previous drugs. There is now a sufficient amount of literature published to interest a wide multidisciplinary readership (general physicians, general neurologists, clinical psychologists, neurologists in training, and medical students) facing every day this burdensome disorder in their clinical practice. The book aims therefore at offering an overview of these new drugs for both acute and prophylactic treatments of migraine, covering studies on clinical evidence, tolerability, and the different stages of clinical development.
650 0 $a Migraine $x Treatment. $3 1005999
650 0 $a Synthetic drugs. $3 3321136
650 1 4 $a Internal Medicine. $3 858559
650 2 4 $a Neurology. $3 588698
650 2 4 $a Emergency Medicine. $3 858957
650 2 4 $a Pain Medicine. $3 894344
650 2 4 $a Pharmacology. $3 634543
700 1 $a Martelletti, Paolo. $3 3217819
700 1 $a Edvinsson, Lars. $3 3599569
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
830 0 $a Headache. $3 2132792
856 4 0 $u https://doi.org/10.1007/978-3-030-95334-8
950 $a Medicine (SpringerNature-11650)